Cargando…
Alterations in Circulating miRNA Levels after Infection with SARS-CoV-2 Could Contribute to the Development of Cardiovascular Diseases: What We Know So Far
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and poses significant complications for cardiovascular disease (CVD) patients. MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and influence several...
Autores principales: | Pieri, Myrtani, Vayianos, Panayiotis, Nicolaidou, Vicky, Felekkis, Kyriacos, Papaneophytou, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917196/ https://www.ncbi.nlm.nih.gov/pubmed/36768701 http://dx.doi.org/10.3390/ijms24032380 |
Ejemplares similares
-
Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities
por: Felekkis, Kyriacos, et al.
Publicado: (2023) -
Detection of SARS-CoV-2–Specific Antibodies in Human Breast Milk and Their Neutralizing Capacity after COVID-19 Vaccination: A Systematic Review
por: Nicolaidou, Vicky, et al.
Publicado: (2023) -
Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases
por: Felekkis, Kyriacos, et al.
Publicado: (2020) -
Special Issue: The Impact of Early Life Nutrition on Gut Maturation and Later Life Gut Health
por: Pieri, Myrtani, et al.
Publicado: (2023) -
A bovine miRNA, bta‐miR‐154c, withstands in vitro human digestion but does not affect cell viability of colorectal human cell lines after transfection
por: Pieri, Myrtani, et al.
Publicado: (2022)